关注
Srushti Mahajan
Srushti Mahajan
Ph. D. Scholar at NIPER Hyderabad
在 niperhyd.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
I Maji, S Mahajan, A Sriram, P Medtiya, R Vasave, DK Khatri, R Kumar, ...
Journal of Controlled Release 337, 646-660, 2021
742021
Nanomedicine as a magic bullet for combating lymphoma
S Mahajan, M Aalhate, SK Guru, PK Singh
Journal of Controlled Release 347, 211-236, 2022
122022
Traversing the diverse avenues of exopolysaccharides-based nanocarriers in the management of cancer
P Paul, R Nair, S Mahajan, U Gupta, M Aalhate, I Maji, PK Singh
Carbohydrate Polymers 312, 120821, 2023
102023
Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer
M Aalhate, S Mahajan, H Singh, SK Guru, PK Singh
Drug Delivery and Translational Research 13 (6), 1621-1653, 2023
102023
Core-Shell Type Lipidic and Polymeric Nanocapsules: The Transformative Multifaceted Delivery Systems
A Mehandole, N Walke, S Mahajan, M Aalhate, I Maji, U Gupta, NK Mehra, ...
AAPS Pharmscitech 24 (1), 50-50, 2023
92023
Nanomedicine: A pragmatic approach for tackling melanoma skin cancer
VM Prajapat, S Mahajan, PG Paul, M Aalhate, A Mehandole, J Madan, ...
Journal of Drug Delivery Science and Technology 83, 104394, 2023
82023
Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic
R Nair, P Paul, I Maji, U Gupta, S Mahajan, M Aalhate, SK Guru, PK Singh
Carbohydrate Polymers, 121644, 2023
72023
A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer
A Shettiwar, U Gupta, P Paul, R Nair, M Aalhate, S Mahajan, I Maji, ...
Journal of Drug Delivery Science and Technology, 104990, 2023
52023
Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy
A Dhuri, A Sriram, M Aalhate, S Mahajan, KK Parida, H Singh, U Gupta, ...
Pharmaceutical Development and Technology 28 (5), 460-478, 2023
52023
Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro …
MAM Ateeq, M Aalhate, S Mahajan, GS Kumar, S Sen, H Singh, U Gupta, ...
Drug delivery and translational research, 2023
52023
Formulation of inclusion complex of abiraterone acetate with 2-hydroxypropyl-beta-cyclodextrin: physiochemical characterization, molecular docking and bioavailability evaluation
M Tamizhmathy, U Gupta, A Shettiwar, GS Kumar, S Daravath, M Aalhate, ...
Journal of Drug Delivery Science and Technology 82, 104321, 2023
52023
Nanotoxicology: toxicity and safety issues of nanoparticles
I Maji, S Mahajan, A Sriram, NK Mehra, S Srivastava, J Madan, SB Singh, ...
Multifunctional Nanocarriers, 461-474, 2022
42022
Budding multi-matrix technology—a retrospective approach, deep insights, and future perspectives
A Sriram, S Tangirala, S Atmakuri, S Hoque, S Modani, S Srivastava, ...
AAPS PharmSciTech 22, 1-40, 2021
42021
Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer
BN Saren, S Mahajan, M Aalhate, R Kumar, E Chatterjee, I Maji, U Gupta, ...
Colloids and Surfaces B: Biointerfaces 233, 113631, 2024
32024
Polymeric nanomaterials: fundamentals and therapeutic applications
I Maji, S Mahajan, A Sriram, NK Mehra, PK Singh
Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic …, 2023
32023
Current status of FDA-approved marketed nano drug products: regulatory considerations
VT Banala, D Mukherjee, S Mahajan, PK Singh
Multifunctional Nanocarriers, 501-521, 2022
32022
Fabrication of β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin inclusion complexes of Palbociclib: Physicochemical characterization, solubility enhancement, in-silico studies …
P Paul, U Gupta, R Kumar, S Munagalasetty, HP Padhy, R Nair, ...
Journal of Molecular Liquids 399, 124458, 2024
22024
Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept
K Khaparkhuntikar, I Maji, SK Gupta, S Mahajan, M Aalhate, A Sriram, ...
Journal of Biomolecular Structure and Dynamics 42 (3), 1469-1484, 2024
22024
Vesicular Nanomaterials: Types and Therapeutic Uses
S Mahajan, I Maji, NK Mehra, PK Singh
Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic …, 2023
22023
Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety
A Mehandole, S Mahajan, M Aalhate, R Kumar, I Maji, U Gupta, SK Guru, ...
International Journal of Pharmaceutics 651, 123784, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–20